HENRY ANHALT, DO, FAAP, FACOP, FACE, CDE - Pediatric Endocrinologist
Dr. Henry Anhalt is the Director, Medical Affairs at Animas Corporation.

Prior to his appointment at Animas he was Director, division of pediatric endocrinology and diabetes at the Saint Barnabas Medical Center in New Jersey and at the Infant's and Children's Hospital of Brooklyn at Maimonides Medical Center in Brooklyn. Dr. Anhalt has published widely in both the lay press and the scientific literature on a variety of topics in pediatric endocrinology and diabetes. He serves on the Advocacy and Public Outreach Core Committee of the Endocrine Society and the Public Policy Committee of the Lawson Wilkins Pediatric Endocrine Society. Dr. Anhalt maintains an active clinical practice in Hackensack, NJ and is known as a compassionate leader in diabetes care; he is a certified diabetes educator and champions the use of pump therapy and continuous glucose monitoring technology in all children with diabetes. Dr. Anhalt is a sought after speaker and is often quoted in the Wall St. Journal, LA Times, and CNN. He lectures widely both in the United States and internationally. Hide expanded bio>>

RICHARD J. AUCHUS, M.D., Ph.D. - Associate Professor of Internal Medicine,
Dr. Richard Auchus received his S.B. in chemistry from Massachusetts Institute of Technology and his medical degree and doctorate in pharmacology from Washington University.

He completed an internship and residency in Internal Medicine at the University of Iowa Hospitals and Clinics and a fellowship in Endocrinology at the Wilford Hall USAF Hospital and the University of Texas Health Sciences Center in San Antonio. He did postdoctoral work and training at the University of California, San Francisco prior to joining the faculty at the University of Texas Southwestern Medical Center in Dallas, Texas.

Dr. Auchus has been the recipient of several awards and honors such as Burroughs Wellcome Clinical Scientist Award in Translational Research and the Jean D. Wilson, M.D. Award for Excellence in Scientific Mentoring at UT Southwestern. His memberships in professional organizations include the American College of Physicians/American Society of Internal Medicine, the Endocrine Society and the Dallas County Medical Society/Texas Medical Association. He has authored over 90 journal articles and book chapters, and he has presented at a diverse range of national and international conferences. His group is active in research projects ranging from basic chemical principles of steroid biosynthetic enzymes to clinical and translational investigation in disorders of the pituitary, adrenals, ovaries, and testes that cause hypertension, infertility, and obesity. The common theme of all his work is steroid and sterol biosynthesis and action with an emphasis on human diseases. He collaborates with a range of investigators spanning a broad range of science from clinical neurobiology to basic mechanisms of nematode lifecycles. His clinical interests also focus on pituitary, adrenal, and reproductive diseases that involve disorders of steroid production. Hide expanded bio>>

RICARDO AZZIZ, M.D., M.P.H., M.B.A. - Reproductive Endocrinologist
Dr. Azziz is the Chair of the Department of Obstetrics and Gynecology and the Director of the Division of Reproductive Endocrinology and Infertility at Cedars-Sinai Medical Center in Los Angeles.

Dr. Azziz received a M.D. from the Pennsylvania State University College of Medicine, Hershey, PA. He completed a Residency in Obstetrics and Gynecology at The Georgetown University Hospital, Washington, DC; and a Fellowship in Reproductive Endocrine/Infertility at The Johns Hopkins University, School of Medicine, Baltimore Maryland. At UAB, Dr. Azziz also completed a Masters in Public Health (MPH) in 1995 and a Masters in Business Administration (MBA) in 2000.

Dr. Azziz is a former Chair of the Advisory Committee on Reproductive Health Drugs, of the U.S. Food and Drug Administration; and a member of the Reproductive Endocrinology Study Section of the National Institutes of Health. Dr. Azziz has published over 200 original articles, book chapters, and reviews. He is editor of the text, Practical Manual of Operative Laparoscopy and Hysteroscopy (along with Dr. Ana Murphy), published by Springer-Verlag, now in its second edition and translated into Chinese; and Editor-in-Chief of Androgen Excess Disorders in Women (along with Drs. John E. Nestler and Didier Dewailly), published by Lippincott-Raven. Dr. Azziz is an active reviewer for the Journal of Clinical Endocrinology and Metabolism, where he served as member of its Editorial Board from 1992-1996; and Fertility and Sterility, on whose Editorial Board he currently serves, among others.

Dr Azziz's research interests include the study of the polycystic ovary syndrome (PCOS, the non-classic adrenal hyperplasias (NCAH); the role of the adrenal in hyperandrogenic disorders; the genetics of hyperandrogenic disorders including PCOS and NCAH; the treatment of hirsutism; the regulation and physiology of adrenal androgens; and credentialing and cost-effectiveness of operative endoscopy for pelvic reconstruction. He is currently funded by the U.S. National Institutes of Health for some of these studies.Hide expanded bio>>

SUSAN W. BAKER, Ph.D. - Psychoendocrinologist
Dr. Susan Baker is an Assistant Professor in the Department of Pediatrics, Adrenal Steroids Disorders Program, at Mount Sinai School of Medicine.

Dr. Baker joined Dr. Maria New's group in 1977. Since that time, she has followed patients with classical and non-classical congenital adrenal hyperplasia (CAH), both clinically and through research. Dr. Baker and her colleagues have investigated cognitive strengths and weaknesses in CAH, as well as the effects of prenatal treatment on the condition. At present, they are engaged in an adult follow-up study of classical and non-classical CAH in women aged 18 and over.

Dr. Baker is the co-author of the article, "Psychosexual Quality of Life in Adult Intersexuality: The Example of Congenital Adrenal Hyperplasia (CAH)," in "The Therapeutic Outcome of Endocrine Disorders: Efficacy, Innovation, Quality of Life" (pp. 200-208, Springer Verlag, New York, 2000). Hide expanded bio>>

SHERI A. BERENBAUM, Ph.D. - Psychologist
Dr. Sheri Berenbaum is a Professor in the Psychology Department at Penn State University. Dr. Berenbaum's research focuses on the development of individual differences in cognition and social behavior from a neuroscience perspective.

She is particularly interested in the effects of prenatal sex hormones on the development of sex-typed behaviors and how these effects are mediated directly by the brain and indirectly through the social environment. Much of her work has focused on the study of the human behavioral effects of prenatal hormones in children and adults who were exposed to high levels of androgens early in life because of congenital adrenal hyperplasia (CAH). This research has been supported by the National Institutes of Health since 1985.

Dr. Berenbaum earned her doctoral degree in psychology from the University of California, Berkeley. She completed a postdoctoral fellowship in behavioral genetics at the University of Minnesota, where she first saw a patient with CAH and began the research that would continue for over 20 years. Dr. Berenbaum has served on the faculty of the University of Health Sciences/Chicago Medical School, and the Southern Illinois University School of Medicine.

Dr. Berenbaum is an editor of the journal, Behavior Genetics, and a member of the editorial board of the journal Brain and Cognition. She currently serves on committees concerned with the medical and psychological treatment of children with ambiguous genitalia, including the North American Task Force on Intersexuality.Hide expanded bio>>

FELIX CONTE, M.D. - Pediatric Endocrinologist
Dr. Felix Conte is presently Professor Emeritus in Pediatrics at the University of California in San Francisco.

Dr Conte is a graduate of Columbia University, New York University School of Medicine and was a resident in Pediatrics at Bellevue Hospital in New York City. Subsequently he was a fellow in pediatric endocrinology at Babies Hospital and University of California San Francisco (UCSF) under the tutelage of Dr Melvin Grumbach and Dr Selna Kaplan. In 1970, he was appointed as an Assistant Professor at UCSF and has worked together with them ever since. During his tenure at UCSF he has helped train over 100 fellows from all over the world and has published numerous articles and chapters about pediatric endocrine conditions. He has had a particular interest in children with atypical genitalia. Hide expanded bio>>

ALEJANDRO DIAZ, M.D. - Pediatric Endocrinologist
Dr. Alejandro Diaz graduated from La Universidad del Valle in Cali, Colombia and was trained in general pediatrics at Miami Children's Hospital.

He completed his specialization in Pediatric Endocrinology at NewYork-Presbyterian Hospital/Weill Cornell Medical College. He remained at Cornell as an attending assistant professor in Pediatric Endocrinology.

Dr. Diaz's special interests are in the care of children with short stature, thyroid disorders, disorders of puberty, congenital adrenal hyperplasia, obesity, and diabetes. He has been involved in clinical research of patients with certain genetic conditions concerning growth failure and small birth weight (i.e. Bloom's syndrome). He is also part of the multidisciplinary team involved in the care of individuals with congenital adrenal hyperplasia, Fanconi's anemia, Bloom's syndrome, and thalassemia.

He has participated in research on congenital adrenal hyperplasia. Currently, he is involved in the development of research protocols on overweight children to help promote healthy weight and lifestyles. Hide expanded bio>>

WALTER FUTTERWEIT, M.D.- Adult Endocrinologist
As a clinical endocrinologist and researcher with a particular interest in androgens and women's health, Dr. Walter Futterweit has devoted the past 25 years to the study of polycystic ovary conditions (PCOD and PCOS) and their pathophysiology, treatment, and manifestations, as well as CAH and other diseases of androgen excess.

Dr. Futterweit's interest in androgens and women's health stems from his early training as a clinical endocrinologist and researcher. After completing a Fellowship at Mt. Sinai Hospital and training at the Worcester Foundation of Experimental Biology, Dr. Futterweit received a 2-year NIH grant for the study of androgens utilizing the assay he had developed at the Worcester Foundation. Since then, he has participated in several symposia on PCOS, and published numerous articles, reviews, abstracts, textbook chapters, as well as a book on PCOD.

Dr. Futterweit is currently a Clinical Professor of Medicine at the Mt. Sinai Medical Center and continues to be active in national and international meetings in developing proposed guidelines for endocrinologists who treat PCOS. He has been elected to the Advisory Board of Polycystic Ovarian Syndrome Association (PCOSA), a national organization of women with PCOS, as well as to the board of the Androgen Excess Society, and often lectures at their meetings.Hide expanded bio>>

MITCHELL E. GEFFNER, M.D.- Pediatric Endocrinologist
Dr. Geffner is currently Professor of Pediatrics and Director of Fellowship Training in the Division of Endocrinology, Diabetes, and Metabolism at Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, and formerly the Chief of the Division of Pediatric Endocrinology at the Mattel Children's Hospital at UCLA.

He graduated from Queens College of the City University of New York in 1972 and from the Albert Einstein College of Medicine in 1975. Dr. Geffner was an intern, resident, and chief resident at the Los Angeles County-University of Southern California Medical Center between 1975-1979. He completed a three-year fellowship in Pediatric Endocrinology at UCLA between 1979-1982. He remained at UCLA through December 31, 2001, having risen up the academic ladder to the rank of Professor in 1996.

Under the mentorship of Drs. Solomon Kaplan, Barbara Lippe, and David Golde, Dr. Geffner developed a long-standing basic research interest in the general area of hormone resistance. More specifically, he has studied the mechanisms responsible for resistance to ACTH (in the triple A syndrome), thyroid hormones, growth hormone (Laron dwarfism), and combined GH and IGF-I resistance (African Efe Pygmies and HIV-1-infected children with growth failure).

To date, Dr. Geffner has authored over 100 peer-reviewed publications and review articles. On a clinical level, his research interests have involved studies of new formulations, delivery systems, indications for GH therapy, and optimization of treatment for children with Type 2 diabetes mellitus.

Dr. Geffner has had a career-long interest in medical and patient education. He served as the Chairman of the Program Directors' Committee of the Lawson Wilkins Pediatric Endocrine Society (LWPES) for six years, and is currently on the LWPES Program and Education Committees. Dr. Geffner was recently named to the Endocrinology Sub-Board of the American Academy of Pediatrics. He is also a medical advisor to the Turner Syndrome Society of Southern California, a medical advisor on childhood panhypopituitarism for the MAGIC Foundation and the Pituitary Network, a member of the Scientific & Medical Advisory Board of the CARES Foundation, and a member of the National Steering Committee for the NIH-sponsored TODAY (Treatment Of type 2 Diabetes in Adolescents and Youth) trial and the Scientific Leadership Group of the NIH-sponsored Pediatric HIV AIDS Cohort Study (PHACS). Lastly, Dr. Geffner is co-editor of the current edition of "Principles and Practice of Pediatric Endocrinology" (formerly the Wilkins' Textbook) and co-author of the chapters on Puberty and Hypoglycemia.

Books Written
Kappy M, Geffner M, Allen D (eds), Principles and Practice of Pediatric Endocrinology (1st ed). Charles C. Thomas, 2005.Hide expanded bio>>

CLAUDE MIGEON, M.D. - Pediatric Endocrinologist
Dr. Migeon received his M.D. from the University of Paris (France) and received Pediatric training at the Hopital des Enfants Malades/Necker. He came to Johns Hopkins Hospital in 1950 as a Fulbright Fellow and with the support of the American Field Service. From 1950-52, he was Fellow-in-Residence in the group of Lawson Wilkins.

This was the time when CAH patients were treated with cortisone and salt-retaining hormones for the first time in the world. From 1952-55, he learned steroid chemistry and biology at the University of Utah in Salt Lake City under the direction of Dr. Leo T. Samuels. In 1955, he returned to Hopkins to direct the laboratories of Dr. Wilkins.

For 20 years (1974 - 1994), he was Director of the Pediatric Endocrine Clinic at Hopkins. During the past 50 years, he has been involved in many aspects of endocrinology, particularly gonadal and adrenal function. With more than 100 Fellows trained in the clinic, he published about 400 scientific papers. At this time, he continues to treat children with endocrine problems and he is involved in the study of follow-up to patients with intersex and with CAH.Hide expanded bio>>

WALTER L. MILLER , M.D. - Pediatric Endocrinologist
Dr. Walter L. Miller is Professor of Pediatrics and Chief of Endocrinology at the University of California, San Francisco, where he holds joint appointments in the Center for Reproductive Sciences and the Human Genetics Program.

Dr. Miller received his S.B. in Philosophy from the Massachusetts Institute of Technology in 1965 and his M.D. from Duke University in 1970. He did two years of residency in pediatrics at the Massachusetts General Hospital, two years of general endocrinology in the USPHS at NIH. He then moved to San Francisco for a third year of residency, a two-year fellowship in biochemistry and one year of pediatric endocrinology before joining the faculty in 1978. He was promoted to Associate Professor in 1983, to Professor in 1987, and named Division Chief in 2000.

Dr. Miller is internationally known for his landmark work in the molecular biology of steroid hormone synthesis. His laboratory cloned many of the genes for steroidogenic enzymes and their co-factors, and elucidated the molecular basis of eight diseases, including three forms of congenital adrenal hyperplasia: due to deficiencies of steroidogenic acute regulatory protein (StAR), the cholesterol side-chain cleavage system (P450scc), and P450 oxidoreductase (POR), as well as recessive Ehlers-Danlos syndrome and pseudo vitamin D-deficiency rickets. His group described the post-translational regulation of androgen synthesis, and has used clinical investigation, molecular and cellular biology, biophysics and computational imaging to study human disease. Dr. Miller was the co-chair of the LWPES/ESPE consensus conference on CAH and principal author of the consensus statement published in 2002.

Over 70 students and fellows have trained with Dr. Miller in his laboratory, and another 28 have studied Pediatric Endocrinology under his direction. Dr. Miller has received the Ross Research Award from the Western Society for Pediatric Research, the Edwin B. Astwood Award and the Clinical Investigator Award from the Endocrine Society, the Clinical Endocrinology Trust Medal from the British Endocrine Society, and the Samuel Rosenthal Foundation Prize for Excellence in Academic Pediatrics. Dr. Miller is active in numerous societies and editorial boards, served on the Biochemical Endocrinology Study Section, the Basil O'Connor Advisory Committee of the March of Dimes, and currently serves on the Board of Scientific Counselors of the National Institute of Child Health and Human Development. Hide expanded bio>>

MARIA I. NEW, M.D. - Pediatric and Adult Endocrinologist
Recipient of The Endocrine Society's highest award, The Koch Award, and a member of the National Academy of Sciences, Dr. Maria New is Professor of Pediatrics and Director of the Adrenal Steroids Disorders Program at Mount Sinai School of Medicine.

Dr. New's research focuses on intersex, childhood hypertension, and adrenal steroid disorders, particularly CAH. She is developing gene therapy for CAH.

Dr. New is responsible for a number of scientific breakthroughs in the study of CAH. She runs the largest CAH clinic in the United States and one of the largest in the world. It is the only large center that provides prenatal diagnosis of CAH and prenatal treatment of affected females to prevent genital ambiguity. Dr. New's Laboratory of Molecular Endocrinology is an international resource for molecular genetic diagnosis of many hormone disorders and provides routine DNA analysis of the 21-hydroxylase gene, the mutation of which causes CAH.

Dr. New received her M.D. from the University of Pennsylvania, where she was awarded the Distinguished Graduate Award. The many honors Dr. New has received include election to the National Academy of Sciences, the Institute of Medicine of the National Academy of Sciences, and the American Academy of Arts & Sciences. Dr. New has been awarded the MERIT Award of the National Institute of Child Health & Development recognizing her research in adrenal disorders, the Dale Medal of the British Endocrine Society, the General Clinical Research Center Award for Excellence in Clinical Research and the Robert H. Williams Distinguished Leadership Award in Endocrinology.

Dr. New has been President of both the Endocrine Society and the Lawson Wilkins Pediatric Endocrine Society and Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism. Among her multiple advisory positions in federal, state, and city organizations, she is presently a member of the New York State Public Health Council and the National Advisory Research Council of the National Institute of Child Health and Human Development.Hide expanded bio>>

SHARON E. OBERFIELD, M.D. - Professor of Pediatrics
Dr. Sharon Oberfield is the Director of the Division of Pediatric Endocrinology, Diabetes and Metabolism and the Program Director of the Fellowship Training Program at Columbia University Medical Center, New York Presbyterian Hospital.

In the past Dr. Oberfield has been a Director of the Lawson Wilkins Pediatric Endocrine Society (LWPES) and chaired its Drug and Therapeutics Committee. She is the current Chair of the LWPES Program Directors Committee. Dr. Oberfield is also a member of the Endocrine Society and its Clinical Guidelines Subcommittee. She is the author or co-author of more than 125 articles, multiple chapters and reviews. She is also an invited speaker at national and international meetings on topics related to disorders of the adrenal gland and puberty.Hide expanded bio>>

DIX P. POPPAS, M.D., F.A.A.P., F.A.C.S. - Pediatric Urologist
Dr. Dix Poppas is Chief of Pediatric Urology at the Children's Hospital of New York - Weill Medical College of Cornell University.

Dr. Poppas is the Richard Rodgers Associate Professor of Pediatric Urology in the James Buchanan Brady Department of Urology at Weill Medical College. He holds joint appointments as Associate Professor of Pediatrics and Associate Professor of Plastic and Reconstructive Surgery at Weill Medical College. Dr. Poppas' practice is limited to pediatric urology with special interest in genital reconstruction, laparoscopy and intersex disorders. He serves as Director of the Laboratory for Minimally Invasive Urologic Surgery.

Dr. Poppas is a Diplomat of the American Board of Urology, a Fellow of the American Academy of Pediatrics and a Fellow of the American College of Surgeons. He has published over 60 peer-reviewed manuscripts and over 12 book chapters relating to his clinical and basic science research.Hide expanded bio>>

RICHARD C. RINK, M.D. - Pediatric Urologist
Dr. Richard C. Rink is a graduate of Indiana University School of Medicine. His general surgical training was at Emory University in Atlanta, Georgia. He returned to Indiana University where he completed his Urology Residency.

He then did a Pediatric Urologic Fellowship at The Children's Hospital, Boston at Harvard Medical School. In 1985, he joined the Pediatric Urology Faculty at the James Whitcomb Riley Hospital for Children at Indiana University. In 1989, he became Chief of Pediatric Urology and in 1996 was named the Robert A. Garrett Professor of Pediatric Urologic Research.

Dr. Rink is a member of many prestigious national and international organizations including the American Academy of Pediatrics (AAP), American College of Surgeons, The Society of Pediatric Urology, The European Society of Pediatric Urology, and the American Urologic Association (AUA). He has served on the Executive Committees of the Society of Genitourinary Reconstructive Surgeons (GURS), the American Academy of Pediatrics-Section on Urology, and the North Central Section of the AUA. He is past-president of both the GURS and American Association of Pediatric Urologists. He is President-elect of the AAP-Section on Urology.

Dr. Rink has authored or co-authored over 120 journal articles and 20 Textbook chapters. He is co-editor of the new textbook, Pediatric Urology. He and his associates have established one of the premier Pediatric Urologic Fellowship training programs in the world. He has been named one of "The Best Doctors in America" and "America's Top Rated Physicians." His primary interest is in pediatric genital reconstructive procedures and reconstruction of the lower urinary tract in children. He has a tremendous amount of experience in reconstruction for Congenital Adrenal Hyperplasia and has reported several innovative surgical techniques for these children. He has lectured throughout the world on this topic.Hide expanded bio>>

SCOTT A. RIVKEES, M.D. - Pediatric Endocrinologist
Scott A. Rivkees, MD, a board-certified specialist in pediatric endocrinology, is an Associate Professor of Pediatrics, in the Section of Pediatric Endocrinology at Yale University School of Medicine.

Dr. Rivkees received his MD from the University of Medicine and Dentistry of New Jersey, and completed residencies in Pediatrics at Massachusetts General Hospital and Harvard Medical School in Boston. His postgraduate training includes a fellowship in Pediatric Endocrinology at Massachusetts General Hospital and Harvard Medical School in Boston. He also received postdoctoral training in neuroscience at Massachusetts General Hospital.

Dr. Rivkees is the recipient of multiple National Institutes of Health and foundation-sponsored research grants and has trained more than 10 postdoctoral fellows. He has an active clinical and basic science research program. He has published more than 100 original and review articles in scientific journals and serves on multiple editorial boards and National Institutes of Health review panels. Dr. Rivkees is a fellow of the American Academy of Pediatrics and the American Society for Clinical Investigation. He currently is a member of the State of Connecticut's General Advisory Committee and is active in the Lawson Wilkins Pediatric Endocrine Society. Dr. Rivkees also has been an expert witness for the United States Senate Children and Family Subcommittee.Hide expanded bio>>

RICHARD JM ROSS, Ph.D., MBBS, M.D., FRCP - Endocrinologist
Richard JM Ross is Professor of Endocrinology, Head of Section Endocrinology & Reproduction, Sheffield University.

Professor Ross trained in medicine at The Royal London Hospital (1974-1979) and in Endocrinology at St Bartholomew's Hospital, London (1983-1988). He is Head of the Section of Endocrinology and Reproduction and serves on the School Council.

Professor Ross's research and clinical interests are in Pituitary Disease. His research has yielded some 130 papers in peer reviewed journals, over 50 chapters and two books. He has a particular interest in commercial research. He is a Knowledge Transfer Champion in the university, and founding Director of two university spin-out companies; Asterion Ltd and Diurnal Ltd. He has 9 granted patents and over 100 filed patents and obtained Orphan Drug Designation from the EMEA for Chronocort; a new therapy for Adrenal Insufficiency. Hide expanded bio>>

DAVID E. SANDBERG, Ph.D. – Pediatric Psychologist
Dr. David Sandberg is Associate Professor and Director of the Division of Child Behavioral Health in the Department of Pediatrics and Communicable Diseases at the University of Michigan in Ann Arbor.

Dr. Sandberg is a child and adolescent clinical psychologist with expertise in caring for youths with chronic medical conditions and their families. For over 18 years, he has served as a member of healthcare professional teams caring for youths with various endocrine conditions.  His clinical research program flows from these clinical experiences, including studies of the psychosocial aspects of short stature and examination of assumptions underlying growth hormone therapy. A second focus is the psychological development of children born with conditions identified by newborn screening. He has developed a psychoeducational treatment manual for clinicians caring for newborns with congenital adrenal hyperplasia and is designing health-related quality-of-life questionnaires for patients with conditions affecting sexual or reproductive function and their parents.

Dr. Sandberg obtained his doctorate from Concordia University in Montreal, Canada and completed postdoctoral fellowships at the University of Miami and at the College of Physicians & Surgeons of Columbia University. He is a member of the Lawson Wilkins Pediatric Endocrine Society, is a Fellow of the American Psychological Association and the Society of Pediatric Psychology, and is on the editorial board of the Journal of Pediatric Psychology.Hide expanded bio>>

ELLEN W. SEELY, M.D. - Adult Endocrinologist
Ellen W. Seely, M.D. is the Director of Clinical Research, in the Division of Endocrinology, Diabetes and Hypertension at the Brigham and Women's Hospital in Boston, Massachusetts and Associate Professor of Medicine at Harvard Medical School.

Dr. Seely is a graduate of Brown University, and she received her medical degree from Columbia University's College of Physicians and Surgeons. She then completed her internal medicine and endocrinology fellowship training at Brigham and Women's Hospital.

Dr. Seely is a leader in patient-oriented research of the physiology of blood pressure regulation in women during pregnancy and following menopause. Her research has focused on understanding cardiovascular risk factors in women. She is the principal investigator on three NIH projects. She is a committed mentor and won the 2001 A. Clifford Barger Award in Excellence in Mentoring from Harvard Medical School. She currently serves on the Research Affairs Committee of the Endocrine Society and the Cardiovascular Endocrinology Task Force. Clinically, she sees women with endocrine problems complicating pregnancy. She has lectured widely on CAH and pregnancy.

Dr. Seely is also a Fellow of the Council for High Blood Pressure Research of the American Heart Association and has been designated a Clinical Specialist in hypertension by the American Society of Hypertension. She serves on the editorial board of the Journal of Endocrinology and Metabolism and has been selected for inclusion in Who's Who in Medicine and Healthcare, and Who's Who in America. She has been named one of Boston's Top Doctors for Women in Endocrinology, Boston Magazine, 2001.Hide expanded bio>>

PHYLLIS W. SPEISER, M.D. - Pediatric Endocrinologist
Dr. Phyllis Speiser is Director of Pediatric Endocrinology for the North Shore-Long Island Jewish Health System in New York and Professor of Clinical Pediatrics at New York University School of Medicine.

Dr. Speiser is an internationally recognized expert in congenital adrenal hyperplasia (CAH). Her research has mainly focused on genetic and clinical correlations among patients with adrenal disorders. Dr. Speiser's research on CAH has been published in the New England Journal of Medicine, the Journal of Clinical Investigation and the Journal of Endocrinology and Metabolism, where she serves on the Editorial Board. Dr. Speiser recently edited and published a symposium on congenital adrenal hyperplasia for the Endocrine and Metabolism Clinics of North America. She is a medical advisor to the National Adrenal Diseases Foundation.Hide expanded bio>>

BRADFORD L. THERRELL, M.S., Ph.D. - Chemist/Administrator
Dr. Brad Therrell is a Professor in the Department of Pediatrics at the University of Texas Health Science Center at San Antonio (UTHSCSA), and Director of the National Newborn Screening and Genetics Resource Center (NNSGRC) located in Austin, Texas.

Dr. Therrell previously served for almost 30 years as Director of Chemistry at the Texas Department of Health, where he was responsible for the world's largest newborn screening laboratory. It was under his direction that congenital adrenal hyperplasia (CAH) was added to the newborn screening panel in Texas in 1987.

Dr. Therrell earned his bachelor's degree in chemistry from Mississippi College in Clinton, and his master's and doctoral degrees in inorganic chemistry from the Florida State University in Tallahassee. In 1997, he was presented with an Honorary Doctor of Medicine Degree from Kunming Medical College in Yunnan, China, for his outstanding contributions to the field of newborn screening and for his leadership and cooperation in establishing newborn screening in developing countries.

Dr. Therrell became interested in CAH screening after learning of successful screening efforts in Alaska and Illinois. He collaborated with Dr. Sheri Berenbaum, also a member of the CARES Foundation Board, in accumulating CAH newborn screening information from over 1.8 million Texas newborns in a major published study.

Dr. Therrell has served as co-editor of the journal, Screening, and is a member of the editorial board of the journals, Genetic Testing and Journal of Medical Screening. He is a member of committees concerned with newborn screening issues that are part of the March of Dimes, the Association of Public Health Laboratory Directors, the American College of Medical Genetics, HRSA and the Centers for Disease Control and Prevention (CDC). Additionally, he has authored or co-authored over 120 articles and several book chapters and has edited several books on newborn screening topics.Hide expanded bio>>

MARIA VOGIATZI, M.D. - Pediatric Endocrinologist
A native of Greece, Dr. Vogiatzi graduated from the Medical School of Aristotelian University in Greece and came to New York for further training in Pediatrics. She continued her training in Pediatric Endocrinology at The New York Hospital/ Cornell and Baylor College of Medicine in Houston, TX.

She joined the faculty of Pediatric Endocrinology at Cornell in 1997 and became the director of the program in 2005.

Dr. Vogiatzi has been involved with patients with CAH and their families since she joined Cornell. She worked with Dr. New's team in a study of growth in CAH and in evaluating the long term outcome of males with classical CAH. Her research interests include studies of growth in CAH, the development of a model of comprehensive, multidisciplinary care in CAH and other chronic endocrine disorders and studies of low bone mass (i.e. osteoporosis) in childhood and adolescence. Hide expanded bio>>

GARRY WARNE, M.D. - Pediatric Endocrinologist
Dr. Garry Warne is Senior Endocrinologist at the Royal Children's Hospital, Melbourne, Australia, and Program Director of Royal Children's Hospital International. Dr. Warne's interest in adrenal disorders came during a research fellowship with Dr Jeremy Winter at the Health Sciences Center in Winnipeg, Manitoba (1975-1977).

In 1980, he published the first version of "Your Child with Congenital Adrenal Hyperplasia" at the request of Dot Gronn, the mother of two CAH children. Meetings for parents were held after the book came out, and this group became the world's first CAH Support Group.

Dr. Warne, who studies intersex disorders as well as CAH, has published another parent and patient information book, "Complete Androgen Insensitivity Syndrome." He has created a teaching video for health professionals called "Tell me doctor, boy or girl?" Dr. Warne's work has included laboratory studies on the androgen receptor and its gene, and clinical research on CAH, androgen insensitivity syndrome and Turner's Syndrome. He is currently part of a multi-disciplinary team conducting a long-term follow-up study of patients who had genital surgery early in life. He has helped found a number of support groups in Australia, as well as a CAH support group in Hanoi, Vietnam. He travels regularly to a number of countries in Asia, especially India and Vietnam. Hide expanded bio>>

SELMA FELDMAN WITCHEL, M.D. - Pediatric Endocrinologist
Dr. Selma Witchel is an Associate Professor of Pediatrics at the Children's Hospital of UPMC, University of Pittsburgh, Pittsburgh, PA where she also serves as the Program Director of the Pediatric Endocrine Fellowship Program.

She is a graduate of Oberlin College and the University of Pittsburgh School of Medicine. Following her residency in pediatrics at the Children's Hospital Medical Center in Cincinnati, Ohio, she completed her pediatric endocrine fellowship at the Children's Hospital of Pittsburgh.

Dr. Witchel has a long standing interest in the diagnosis and management of congenital adrenal hyperplasia. She has published many research articles, reviews, and chapters about congenital adrenal hyperplasia, ambiguous genitalia, genetics of disorders associated with androgen excess, and polycystic ovary syndrome. She is a member of the Endocrine Society, Lawson Wilkins Pediatric Society, American Pediatric Society, and the Androgen Excess Society. Hide expanded bio>>